
Labeling and Packaging
Identify errors before your products reach the market.
Minimize errors and avoid costly revisions
Improving labeling and packaging approaches is essential to reducing errors and enhancing healthcare accuracy. Med Safety Board, powered by ECRI and ISMP, helps the pharmaceutical industry and 503B outsourcing companies optimize product labels and packaging to ensure safe use. Though our experts focus on identifying potential labeling errors before products reach the market, helping you save money and time, they can also help identify error-prone labeling and packaging at any phase of the product lifecycle, including post-approval.
Our Approach
Every labeling and packaging design or review project begins with a search of similar product reports submitted to the ISMP National Medication Errors Reporting Program (ISMP MERP). Med Safety Board experts analyze these reports to identify potential errors and strategies to avoid them, ensuring labels meet current standards, guidelines, and regulatory requirements from organizations like the USP, FDA, Health Canada, and EMA, when applicable.
Project considerations include:

Why It Matters
Labeling and packaging-related medication errors are among the most frequently reported to the ISMP National Medication Errors Reporting Program (ISMP MERP). Issues like visual label similarities, missing critical information, and error-prone packaging have contributed to serious medication errors and patient harm. Addressing these problems is crucial to improving medication safety.
Get in Touch
Let's start zeroing in on exactly how we can help.
More Ways We Help

Product and Safety Advisory Boards
Gather actionable end-user feedback from clinicians to identify risks, optimize designs, and improve product safety and outcomes.
Learn More
Drug and Device Risk Assessments
Identify and mitigate risks early using expert-led assessments to ensure safer, market-ready drug and device products.
Learn More